MeiraGTx Holdings (MGTX) Net Income towards Common Stockholders Growth (3y) (2020 - 2025)
MeiraGTx Holdings (MGTX) Net Income towards Common Stockholders Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 45.47% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 91.31% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | MeiraGTx Holdings | 997.33 Mn | 931.40 Mn | - | 36.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.66% |
| Sep 30, 2025 | -10.65% |
| Jun 30, 2025 | -4.52% |
| Mar 31, 2025 | -8.80% |
| Dec 31, 2024 | -58.41% |
| Sep 30, 2024 | -14.87% |
| Jun 30, 2024 | -34.27% |
| Mar 31, 2024 | 4.70% |
| Dec 31, 2023 | 57.84% |
| Sep 30, 2023 | -90.26% |
| Jun 30, 2023 | -5.19% |
| Mar 31, 2023 | -24.64% |
| Dec 31, 2022 | -70.81% |
| Sep 30, 2022 | -52.75% |
| Jun 30, 2022 | -17.72% |
| Mar 31, 2022 | -19.96% |
| Dec 31, 2021 | 22.21% |
| Sep 30, 2021 | -18.93% |
| Jun 30, 2021 | 13.58% |
| Mar 31, 2021 | -11.43% |